Part 15.
TEXAS STATE BOARD OF PHARMACY
Chapter 281.
ADMINISTRATIVE PRACTICE AND PROCEDURES
Subchapter A. GENERAL PROVISIONS
22 TAC §281.9
The Texas State Board of Pharmacy adopts amendments to §281.9,
concerning Rules Governing Penalties Against a License. The amendments are
adopted without changes to the proposed text as published in the December
9, 2005, issue of the
Texas Register
(30 TexReg
8259).
The amendments update the rule in accordance with amendments made to the
Texas Pharmacy Act, §568.0035 authorizing the Board to take the following
disciplinary actions against a pharmacy technician registration: probation,
reprimand, restrict, revoke, suspend, retire, or impose an administrative
penalty. The amendments also clarify the administrative penalties for violations
of the Texas Pharmacy Act or Board rules to ensure that the amount of administrative
penalties imposed for pharmacists, pharmacies, and pharmacy technicians are
appropriate to the violation. In addition, the amendments change the title
of §281.9 from Rules Governing Penalties Against a License to Rules Governing
Disciplinary Actions.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
566.002, and 568.0035 of the Texas Pharmacy Act (Chapters 551 - 566 and 568
- 569, Texas Occupations Code). The Board interprets §551.002 as authorizing
the agency to protect the public through the effective control and regulation
of the practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §566.002 as authorizing the agency to adopt
an administrative penalty schedule. The Board interprets §568.0035 as
authorizing the agency to adopt rules regarding the disciplinary actions against
pharmacy technicians.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600763
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §283.6
The Texas State Board of Pharmacy adopts amendments to §283.6,
concerning Preceptor Requirements. The amendments are adopted without changes
to the proposed text as published in the December 9, 2005, issue of the
The adopted amendments provide procedures and requirements to allow a preceptor
in a Texas College of Pharmacy Internship Program to supervise up to two interns
during an emergency situation.
No comments were received regarding the proposal.
The amendments are adopted under §551.002 and §554.051
of the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas Occupations
Code). The Board interprets §551.002 as authorizing the agency to protect
the public through the effective control and regulation of the practice of
pharmacy. The Board interprets §554.051(a) as authorizing the agency
to adopt rules for the proper administration and enforcement of the Act.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600764
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §283.7
The Texas State Board of Pharmacy adopts amendments to §283.7,
concerning Examination Requirements. The amendments are adopted without changes
to the proposed text as published in the December 9, 2005, issue of the
The amendments clarify the NAPLEX and Texas Pharmacy Jurisprudence Examination
are administered in compliance with the Americans with Disabilities Act.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
and 558.058 of the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as authorizing the agency
to protect the public through the effective control and regulation of the
practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §558.058 as authorizing the agency to adopt
rules to ensure that examinations are administered in compliance with the
Americans with Disabilities Act.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600765
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §283.10
The Texas State Board of Pharmacy adopts amendments to §283.10,
concerning Requirements for Application for a Pharmacist License Which Has
Expired. The amendments are adopted without changes to the proposed text as
published in the December 9, 2005, issue of the
Texas Register
(30 TexReg 8262).
The amendments update the renewal fees required to renew an expired pharmacist
license in accordance with amendments to §559.003 of the Texas Pharmacy
Act.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
and 559.003 of the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as authorizing the agency
to protect the public through the effective control and regulation of the
practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §559.003 as authorizing the agency to adopt
rules regarding the renewal of a pharmacist.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600766
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
Subchapter A. ALL CLASSES OF PHARMACIES
22 TAC §291.6, §291.14
The Texas State Board of Pharmacy adopts amendments to §291.6,
concerning Pharmacy License Fees and §291.14, concerning Pharmacy License
Renewal. The amendments are adopted without changes to the proposed text as
published in the December 9, 2005, issue of the
Texas Register
(30 TexReg 8263).
The amendments update the renewal fees to renew an expired pharmacy license
in accordance with amendments to §561.003 of the Texas Pharmacy Act;
clarify the amount of the pharmacy license renewal fee; and establish additional
renewal requirements for Class E (non-resident) pharmacies.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
560.052, 561.003 and 561.0031 of the Texas Pharmacy Act (Chapters 551 - 566
and 568 - 569, Texas Occupations Code). The Board interprets §551.002
as authorizing the agency to protect the public through the effective control
and regulation of the practice of pharmacy. The Board interprets §554.051(a)
as authorizing the agency to adopt rules for the proper administration and
enforcement of the Act. The Board interprets §560.052 as authorizing
the agency to establish standards for Class E pharmacies to meet in order
to qualify for licensing as a pharmacy. The Board interprets §561.003
as authorizing the agency to adopt rules regarding the renewal of a pharmacy
license. The Board interprets §561.0031 as authorizing the agency to
establish additional renewal requirements for Class E pharmacies.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600768
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §291.13
The Texas State Board of Pharmacy adopts new §291.13,
concerning Emergency Remote Pharmacy License. The new section is adopted without
changes to the proposed text as published in the December 9, 2005, issue of
the
Texas Register
(30 TexReg 8264).
The adopted section provides procedures and requirements for the Board
to grant the holder of a Class A (Community), Class C (Institutional), or
Class D (Clinic) pharmacy the authority to operate a pharmacy and provide
pharmacy services at a remote location during an emergency situation.
No comments were received regarding the proposal.
The new section is adopted under §§551.002, 554.051,
and 560.053 of the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as authorizing the agency
to protect the public through the effective control and regulation of the
practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §560.053 as authorizing the agency to adopt
rules establishing additional pharmacy classifications.
The statutes affected by the new section: Texas Pharmacy Act, Chapters
551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600769
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §291.104
The Texas State Board of Pharmacy adopts amendments to §291.104,
concerning Operational Standards. The amendments are adopted with changes
to the proposed text as published in the December 9, 2005, issue of the
The amendments establish additional standards for Class E pharmacies to
meet in order to qualify for licensure as a pharmacy; clarify patient counseling
requirements for Class E pharmacies; and implement changes made by House Bill
836 to Chapter 562 of the Texas Pharmacy Act during the 79th Regular Session
of the Texas Legislature regarding generic substitution.
One written comment was received from Medco Health Solutions, Inc. Medco
commented that the requirement for a Class E pharmacy to submit proof of creditworthiness
was only intended to apply to the initial licensure of a Class E pharmacy.
The Board agrees with the comment and the adopted amendments reflect this
change.
The amendments are adopted under §§551.002, 554.051,
560.052, and Chapter 562 of the Texas Pharmacy Act (Chapters 551 - 566 and
568 - 569, Texas Occupations Code). The Board interprets §551.002 as
authorizing the agency to protect the public through the effective control
and regulation of the practice of pharmacy. The Board interprets §554.051(a)
as authorizing the agency to adopt rules for the proper administration and
enforcement of the Act. The Board interprets §550.052 as authorizing
the agency to establish standards for Class E pharmacies to meet to qualify
for licensing as a pharmacy. The Board interprets Chapter 562 of the Texas
Pharmacy as authorizing the agency to adopt rules concerning the selection
of generically equivalent drugs.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
§291.104.Operational Standards.
(a)
Licensing requirements.
(1)
A Class E pharmacy shall register annually or biennially
with the board on a pharmacy license application provided by the board.
(2)
On initial application, the pharmacy shall follow the procedures
specified in §291.1 of this title (relating to Pharmacy License Application)
and the provide the following additional information specified in §560.052(c)
and (f) of the Act (relating to Qualifications):
(A)
evidence that the applicant holds a pharmacy license, registration,
or permit issued by the state in which the pharmacy is located;
(B)
the name of the owner and pharmacist-in-charge of the pharmacy
for service of process;
(C)
evidence of the applicant's ability to provide to the board
a record of a prescription drug order dispensed by the applicant to a resident
of this state not later than 72 hours after the time the board requests the
record;
(D)
an affidavit by the pharmacist-in-charge which states that
the pharmacist has read and understands the laws and rules relating to a Class
E pharmacy;
(E)
proof of creditworthiness; and
(F)
an inspection report issued not more than two years before
the date the license application is received and conducted by the pharmacy
licensing board in the state of the pharmacy's physical location.
(i)
A Class E pharmacy may submit an inspection report issued
by an entity other than the pharmacy licensing board of the state in which
the pharmacy is physically located if the state's licensing board does not
conduct inspections as follows:
(I)
an individual approved by the board who is not employed
by the pharmacy but acting as a consultant to inspect the pharmacy;
(II)
an agent of the National Association of Boards of Pharmacy;
(III)
an agent of another State Board of Pharmacy; or
(IV)
an agent of an accrediting body, such as the Joint Commission
on Accreditation of Healthcare Organizations.
(ii)
The inspection must be substantively equivalent to an
inspection conducted by the board.
(3)
On renewal of a license, the pharmacy shall complete the
renewal application provided by the board and, as specified in §561.031
of the Act, provide an inspection report issued not more than three years
before the date the renewal application is received and conducted by the pharmacy
licensing board in the state of the pharmacy's physical location.
(A)
A Class E pharmacy may submit an inspection report issued
by an entity other than the pharmacy licensing board of the state in which
the pharmacy is physically located if the state's licensing board does not
conduct inspections as follows:
(i)
an individual approved by the board who is not employed
by the pharmacy but acting as a consultant to inspect the pharmacy;
(ii)
an agent of the National Association of Boards of Pharmacy;
(iii)
an agent of another State Board of Pharmacy; or
(iv)
an agent of an accrediting body, such as the Joint Commission
on Accreditation of Healthcare Organizations.
(B)
The inspection must be substantively equivalent to an inspection
conducted by the board.
(4)
A Class E pharmacy which changes ownership shall notify
the board within ten days of the change of ownership and apply for a new and
separate license as specified in §291.4 of this title (relating to Change
of Ownership).
(5)
A Class E pharmacy which changes location and/or name shall
notify the board within ten days of the change and file for an amended license
as specified in §291.2 of this title (relating to Change of Location
and/or Name).
(6)
A Class E pharmacy owned by a partnership or corporation
which changes managing officers shall notify the board in writing of the names
of the new managing officers within ten days of the change, following the
procedures in §291.3 of this title (relating to Change of Managing Officers).
(7)
A Class E pharmacy shall notify the board in writing within
ten days of closing.
(8)
A separate license is required for each principal place
of business and only one pharmacy license may be issued to a specific location.
(9)
A fee as specified in §291.6 of this title (relating
to Pharmacy License Fees) will be charged for the issuance and renewal of
a license and the issuance of an amended license.
(10)
The board may grant an exemption from the licensing requirements
of this Act on the application of a pharmacy located in a state of the United
States other than this state that restricts its dispensing of prescription
drugs or devices to residents of this state to isolated transactions.
(11)
A Class E pharmacy engaged in the centralized dispensing
of prescription drug or medication orders shall comply with the provisions
of §291.37 of this title (relating to Centralized Prescription Dispensing).
(12)
A Class E pharmacy engaged in central processing of prescription
drug or medication orders shall comply with the provisions of §291.38
of this title (relating to Central Prescription or Medication Order Processing).
(13)
A Class E (Non-Resident) pharmacy engaged in the compounding
of non-sterile pharmaceuticals shall comply with the provisions of §291.25
of this title (relating to Pharmacies Compounding Non-Sterile Pharmaceuticals).
(14)
A Class E (Non-Resident) pharmacy engaged in the compounding
of sterile pharmaceuticals shall comply with the provisions of §291.26
of this title (relating to Pharmacies Compounding Sterile Pharmaceuticals).
(b)
Prescription dispensing and delivery.
(1)
General.
(A)
All prescription drugs and/or devices shall be dispensed
and delivered safely and accurately as prescribed.
(B)
The pharmacy shall maintain adequate storage or shipment
containers and use shipping processes to ensure drug stability and potency.
Such shipping processes shall include the use of packaging material and devices
to ensure that the drug is maintained at an appropriate temperature range
to maintain the integrity of the medication throughout the delivery process.
(C)
The pharmacy shall utilize a delivery system which is designed
to assure that the drugs are delivered to the appropriate patient.
(D)
All Pharmacists shall exercise sound professional judgment
with respect to the accuracy and authenticity of any prescription drug order
they dispense. If the pharmacist questions the accuracy or authenticity of
a prescription drug order, he/she shall verify the order with the practitioner
prior to dispensing.
(E)
Prior to dispensing a prescription, pharmacists shall determine,
in the exercise of sound professional judgment, that the prescription is a
valid prescription. A pharmacist may not dispense a prescription drug if the
pharmacist knows or should have known that the prescription was issued on
the basis of an Internet-based or telephonic consultation without a valid
patient-practitioner relationship.
(F)
Subparagraph (E) of this paragraph does not prohibit a
pharmacist from dispensing a prescription when a valid patient-practitioner
relationship is not present in an emergency situation (e.g. a practitioner
taking calls for the patient's regular practitioner).
(2)
Drug regimen review.
(A)
For the purpose of promoting therapeutic appropriateness,
a pharmacist shall prior to or at the time of dispensing a prescription drug
order, review the patient's medication record. Such review shall at a minimum
identify clinically significant:
(i)
inappropriate drug utilization;
(ii)
therapeutic duplication;
(iii)
drug-disease contraindications;
(iv)
drug-drug interactions;
(v)
incorrect drug dosage or duration of drug treatment;
(vi)
drug-allergy interactions; and
(vii)
clinical abuse/misuse.
(B)
Upon identifying any clinically significant conditions,
situations, or items listed in subparagraph (A) of this paragraph, the pharmacist
shall take appropriate steps to avoid or resolve the problem including consultation
with the prescribing practitioner. The pharmacist shall document such occurrences.
(3)
Patient counseling and provision of drug information.
(A)
To optimize drug therapy, a pharmacist shall communicate
to the patient or the patient's agent, information about the prescription
drug or device which in the exercise of the pharmacist's professional judgment
the pharmacist deems significant, such as the following:
(i)
the name and description of the drug or device;
(ii)
dosage form, dosage, route of administration, and duration
of drug therapy;
(iii)
special directions and precautions for preparation, administration,
and use by the patient;
(iv)
common severe side or adverse effects or interactions
and therapeutic contraindications that may be encountered, including their
avoidance, and the action required if they occur;
(v)
techniques for self monitoring of drug therapy;
(vi)
proper storage;
(vii)
refill information; and
(viii)
action to be taken in the event of a missed dose.
(B)
Such communication:
(i)
shall be provided with each new prescription drug order;
(ii)
shall be provided for any prescription drug order dispensed
by the pharmacy on the request of the patient or patient's agent;
(iii)
shall be communicated orally in person unless the patient
or patient's agent is not at the pharmacy or a specific communication barrier
prohibits such oral communication; and
(iv)
shall be reinforced with written information. The following
is applicable concerning this written information:
(I)
Written information designed for the consumer, such as
the USP DI patient information leaflets, shall be provided.
(II)
When a compounded product is dispensed, information shall
be provided for the major active ingredient(s), if available.
(III)
For new drug entities, if no written information is initially
available, the pharmacist is not required to provide information until such
information is available, provided:
(-a-)
the pharmacist informs the patient or the patient's agent
that the product is a new drug entity and written information is not available.
(-b-)
the pharmacist documents the fact that no written information
was provided; and
(-c-)
if the prescription is refilled after written information
is available, such information is provided to the patient or patient's agent.
(C)
Only a pharmacist may orally provide drug information to
a patient or patient's agent and answer questions concerning prescription
drugs. Non-pharmacist personnel may not ask questions of a patient or patient's
agent which are intended to screen and/or limit interaction with the pharmacist.
(D)
If prescriptions are routinely delivered outside the area
covered by the pharmacy's local telephone service, the pharmacy shall provide
a toll-free telephone line which is answered during normal business hours
to enable communication between the patient and a pharmacist.
(E)
The pharmacist shall place on the prescription container
or on a separate sheet delivered with the prescription container in both English
and Spanish the local and toll-free telephone number of the pharmacy and the
statement: "Written information about this prescription has been provided
for you. Please read this information before you take the medication. If you
have questions concerning this prescription, a pharmacist is available during
normal business hours to answer these questions at (insert the pharmacy's
local and toll-free telephone numbers)."
(F)
The provisions of this paragraph do not apply to patients
in facilities where drugs are administered to patients by a person required
to do so by the laws of the state (i.e., nursing homes).
(G)
Upon delivery of a refill prescription, a pharmacist shall
ensure that the patient or patient's agent is offered information about the
refilled prescription and that a pharmacist is available to discuss the patient's
prescription and provide information.
(H)
Nothing in this subparagraph shall be construed as requiring
a pharmacist to provide consultation when a patient or patient's agent refuses
such consultation. The pharmacist shall document such refusal for consultation.
(c)
Generic Substitution. Unless compliance would violate the
pharmacy or drug laws or rules in the state in which the pharmacy is located:
(1)
a pharmacist in a Class E pharmacy may dispense a generically
equivalent drug product if:
(A)
the generic product costs the patient less than the prescribed
drug product;
(B)
the patient does not refuse the substitution; and
(C)
the prescribing practitioner authorizes the substitution
of a generically equivalent product; or
(D)
the practitioner or practitioner's agent does not clearly
indicate that the oral or electronic prescription drug order shall be dispensed
as ordered; and
(2)
Pharmacists shall use as a basis for the determination
of generic equivalency as defined in the Subchapter A, Chapter 562 of the
Act, the following.
(A)
For drugs listed in the publication, pharmacists shall
use Approved Drug Products with Therapeutic Equivalence Evaluations (Orange
Book) and current supplements published by the Federal Food and Drug Administration,
within the limitations stipulated in that publication, to determine generic
equivalency. Pharmacists may only substitute products that are rated therapeutically
equivalent in the Orange Book and have an "A" rating. "A" rated drug products
include but are not limited to, those designated AA, AB, AN, AO, AP, or AT
in the Orange Book.
(B)
For drugs not listed in the Orange Book, pharmacists shall
use their professional judgment to determine generic equivalency.
(3)
The pharmacy must include on the prescription order form
completed by the patient or the patient's agent information that clearly and
conspicuously:
(A)
states that if a less expensive generically equivalent
drug is available for the brand prescribed, the patient or the patient's agent
may choose between the generically equivalent drug and the brand prescribed;
and
(B)
allows the patient or the patient's agent to indicate the
choice of the generically equivalent drug or the brand prescribed.
(d)
Therapeutic Drug Interchange. A switch to a drug providing
a similar therapeutic response to the one prescribed shall not be made without
prior approval of the prescribing practitioner. This subsection does not apply
to generic substitution. For generic substitution, see the requirements of
subsection (c) of this section.
(1)
The patient shall be notified of the therapeutic drug interchange
prior to, or upon delivery, of the dispensed prescription to the patient.
Such notification shall include:
(A)
a description of the change;
(B)
the reason for the change;
(C)
whom to notify with questions concerning the change; and
(D)
instructions for return of the drug if not wanted by the
patient.
(2)
The pharmacy shall maintain documentation of patient notification
of therapeutic drug interchange which shall include:
(A)
the date of the notification;
(B)
the method of notification;
(C)
a description of the change; and
(D)
the reason for the change.
(e)
Transfer of Prescription Drug Order Information. Unless
compliance would violate the pharmacy or drug laws or rules in the state in
which the pharmacy is located, a pharmacist in a Class E pharmacy may not
refuse to transfer prescriptions to another pharmacy who is making the transfer
request on behalf of the patient.
(f)
Prescriptions for Schedule II controlled substances. Unless
compliance would violate the pharmacy or drug laws or rules in the state in
which the pharmacy is located, a pharmacist in a Class E pharmacy who dispenses
a prescription for a Schedule II controlled substance issued on a Texas Official
Prescription Form shall:
(1)
mail a copy of the form to the Texas Department of Public
Safety, Electronic Prescription Section, P.O. Box 4087, Austin, Texas 78773
within 30 days of dispensing; or
(2)
electronically send the prescription information to the
Texas Department of Public Safety per their requirements for electronic submissions
within 30 days of dispensing.
This agency hereby certifies that the adoption has been
reviewed by legal counsel and found to be a valid exercise of the agency's
legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600770
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §295.5, §295.7
The Texas State Board of Pharmacy adopts amendments to §295.5,
concerning Pharmacist License or Renewal Fees and §295.7, concerning
Pharmacist License Renewal. The amendments are adopted without changes to
the proposed text as published in the December 9, 2005, issue of the
The amendments update the renewal fees required to renew an expired pharmacist
license in accordance with amendments to §559.003 of the Texas Pharmacy
Act and clarify the amount of the pharmacist license renewal fees.
No comments were received regarding the proposal.
The amendments are adopted under §§551.002, 554.051,
and 559.003 of the Texas Pharmacy Act (Chapters 551 - 566 and 568 - 569, Texas
Occupations Code). The Board interprets §551.002 as authorizing the agency
to protect the public through the effective control and regulation of the
practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §559.003 as authorizing the agency to adopt
rules regarding the renewal of a pharmacist license.
The statutes affected by the amendments: Texas Pharmacy Act, Chapters 551
- 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600771
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
22 TAC §295.6, §295.9
The Texas State Board of Pharmacy adopts new §295.6,
concerning Emergency Temporary Pharmacist License and amendments to §295.9,
concerning Inactive License. The new section and amendments are adopted without
changes to the proposed text as published in the December 9, 2005, issue of
the
Texas Register
(30 TexReg 8268).
The new §295.6 provides procedures and requirements for the Board
to grant a pharmacist, who holds a license to practice pharmacy in another
state, an emergency temporary pharmacist license to practice in Texas. The
amendments to §295.9 provide procedures and requirements to allow Texas
pharmacists whose licenses have been inactive for no more than two years to
reactivate their license prior to obtaining the required continuing education
during an emergency situation.
No comments were received regarding the proposal.
The new section and amendments are adopted under §§551.002,
554.051, and 558.155 of the Texas Pharmacy Act (Chapters 551 - 566 and 568
- 569, Texas Occupations Code). The Board interprets §551.002 as authorizing
the agency to protect the public through the effective control and regulation
of the practice of pharmacy. The Board interprets §554.051(a) as authorizing
the agency to adopt rules for the proper administration and enforcement of
the Act. The Board interprets §558.155 as authorizing the agency to issue
temporary pharmacist licenses.
The statutes affected by the new section and amendments: Texas Pharmacy
Act, Chapters 551 - 566 and 568 - 569, Texas Occupations Code.
This agency hereby certifies that the adoption has been reviewed
by legal counsel and found to be a valid exercise of the agency's legal authority.
Filed with the Office of
the Secretary of State on February 14, 2006.
TRD-200600772
Gay Dodson, R.Ph.
Executive Director/Secretary
Texas State Board of Pharmacy
Effective date: March 6, 2006
Proposal publication date: December 9, 2005
For further information, please call: (512) 305-8037
Chapter 537.
PROFESSIONAL AGREEMENTS AND STANDARD CONTRACTS
Chapter 283.
LICENSING REQUIREMENTS FOR PHARMACISTS
Chapter 291.
PHARMACIES
Subchapter F. NON-RESIDENT PHARMACY (CLASS E)
Chapter 295.
PHARMACISTS
Part 23.
TEXAS REAL ESTATE COMMISSION